These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 21901220)

  • 21. Rate-limiting steps in cytochrome P450 catalysis.
    Guengerich FP
    Biol Chem; 2002 Oct; 383(10):1553-64. PubMed ID: 12452431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytochrome P450 compound I: capture, characterization, and C-H bond activation kinetics.
    Rittle J; Green MT
    Science; 2010 Nov; 330(6006):933-7. PubMed ID: 21071661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathways of arachidonic acid peroxyl radical reactions and product formation with guanine radicals.
    Crean C; Geacintov NE; Shafirovich V
    Chem Res Toxicol; 2008 Feb; 21(2):358-73. PubMed ID: 18159932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytochrome P450 119 Compounds I Formed by Chemical Oxidation and Photooxidation Are the Same Species.
    Su Z; Horner JH; Newcomb M
    Chemistry; 2019 Nov; 25(61):14015-14020. PubMed ID: 23108625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enzyme-substrate complementarity governs access to a cationic reaction manifold in the P450(BM3)-catalysed oxidation of cyclopropyl fatty acids.
    Cryle MJ; Hayes PY; De Voss JJ
    Chemistry; 2012 Dec; 18(50):15994-9. PubMed ID: 23109039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Equilibrium and transient state spectrophotometric studies of the mechanism of reduction of the flavoprotein domain of P450BM-3.
    Sevrioukova I; Shaffer C; Ballou DP; Peterson JA
    Biochemistry; 1996 Jun; 35(22):7058-68. PubMed ID: 8679531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multistate reactivity in styrene epoxidation by compound I of cytochrome p450: mechanisms of products and side products formation.
    Kumar D; de Visser SP; Shaik S
    Chemistry; 2005 Apr; 11(9):2825-35. PubMed ID: 15744771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Affinity isolation and characterization of cytochrome P450 102 (BM-3) from barbiturate-induced Bacillus megaterium.
    Black SD; Linger MH; Freck LC; Kazemi S; Galbraith JA
    Arch Biochem Biophys; 1994 Apr; 310(1):126-33. PubMed ID: 8161195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cooperativity in oxidations catalyzed by cytochrome P450 3A4.
    Ueng YF; Kuwabara T; Chun YJ; Guengerich FP
    Biochemistry; 1997 Jan; 36(2):370-81. PubMed ID: 9003190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Products of cytochrome P450(BioI) (CYP107H1)-catalyzed oxidation of fatty acids.
    Cryle MJ; Matovic NJ; De Voss JJ
    Org Lett; 2003 Sep; 5(18):3341-4. PubMed ID: 12943422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spectroscopic characterization of cytochrome P450 Compound I.
    Jung C; de Vries S; Schünemann V
    Arch Biochem Biophys; 2011 Mar; 507(1):44-55. PubMed ID: 21195047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The mystery of cytochrome P450 Compound I: a mini-review dedicated to Klaus Ruckpaul.
    Jung C
    Biochim Biophys Acta; 2011 Jan; 1814(1):46-57. PubMed ID: 20558327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidative cleavage of esters and amides to carbonyl products by cytochrome P450.
    Peng HM; Raner GM; Vaz AD; Coon MJ
    Arch Biochem Biophys; 1995 Apr; 318(2):333-9. PubMed ID: 7733661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetics of the reduction of cytochrome b5 with mutations in its membrane-binding domain.
    Wu FF; Vergères G; Waskell L
    Arch Biochem Biophys; 1994 Feb; 308(2):380-6. PubMed ID: 7906503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular recognition in (+)-alpha-pinene oxidation by cytochrome P450cam.
    Bell SG; Chen X; Sowden RJ; Xu F; Williams JN; Wong LL; Rao Z
    J Am Chem Soc; 2003 Jan; 125(3):705-14. PubMed ID: 12526670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of kinetic isotope effects to delineate the role of phenylalanine 87 in P450(BM-3).
    Rock DA; Boitano AE; Wahlstrom JL; Rock DA; Jones JP
    Bioorg Chem; 2002 Apr; 30(2):107-18. PubMed ID: 12020135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reconstitution premixes for assays using purified recombinant human cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b5.
    Shaw PM; Hosea NA; Thompson DV; Lenius JM; Guengerich FP
    Arch Biochem Biophys; 1997 Dec; 348(1):107-15. PubMed ID: 9390180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of activation energies for aromatic oxidation by cytochrome P450.
    Rydberg P; Ryde U; Olsen L
    J Phys Chem A; 2008 Dec; 112(50):13058-65. PubMed ID: 18986131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spectroscopic and mechanistic studies on oxidation reactions catalyzed by the functional Model SR complex for cytochrome P450: influence of oxidant, substrate, and solvent.
    Hessenauer-Ilicheva N; Franke A; Wolak M; Higuchi T; van Eldik R
    Chemistry; 2009 Nov; 15(45):12447-59. PubMed ID: 19806618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytochrome p450 compound I.
    Newcomb M; Zhang R; Chandrasena RE; Halgrimson JA; Horner JH; Makris TM; Sligar SG
    J Am Chem Soc; 2006 Apr; 128(14):4580-1. PubMed ID: 16594688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.